# FDA Inspection 1198027 - Neobiosis LLC - February 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/neobiosis-llc/bcf057fa-0219-4cf2-b379-c4996ec8c4a9
Source feed: FDA_Inspections

> FDA Inspection 1198027 for Neobiosis LLC on February 21, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198027
- Company Name: Neobiosis LLC
- Inspection Date: 2023-02-21
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1198027 - 2023-02-21](https://www.keypedia.com/records/fda_inspections/neobiosis-llc/d6e86eb8-b54c-44ff-853b-d541e52b4317)
- [FDA Inspection 1198027 - 2023-02-21](https://www.keypedia.com/records/fda_inspections/neobiosis-llc/42e3661a-f517-4824-97bb-0b86ca09fb88)

Company: https://www.keypedia.com/companies/neobiosis-llc/719335d3-a957-49fd-ba40-de92d15e65e3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d